Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 32Observational 1Expanded_access 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Neoplasms by Site 1Neoplasms 1HER2-positive Breast Cancer 1Breast Neoplasms 1Breast Diseases 1Brain Neoplasms 1

Interventions

abemaciclib 2Alpelisib 2zenocutuzumab 1tucatinib 1selpercatinib 1ribociclib 1pegilodecakin 1iniparib 1eribulin 1Proton Pump Inhibitors 1Lapatinib 1Hydrocortisone 1Everolimus 1Capecitabine 1Ado-Trastuzumab Emtansine 1AM0010 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Breast Neoplasms × tucatinib × Clear all
NCT03424473 2020-02-25

Expanded Access Use of Tucatinib for HER2+ Metastatic Breast Cancer

Seagen Inc.

No longer available
BreastCNS

Brain Neoplasms, Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site

Data powered by HemOnc (CC BY 4.0) Colophon âš¡